The old stand-by drug, aspirin, has been replaced in many medicine cabinets by other pain-killers and headache and fever reducers. Due to its effect on the lining of the stomach and the risk of bleeding and ulcers, aspirin is generally taken regularly only by those with a risk of heart disease.

But researchers have found evidence in test-tube experiments that aspirin has angiogenesis-blocking power, that is, it keeps cancers from creating the blood vessels they need to grow. They caution that these tests have not been done in humans yet and that no one should start taking aspirin to ward off cancer.

Aspirin May Be Newest Cancer Drug – WebMD

First Wal-Mart announced it would slash prescription drug prices on 124 generic drugs, charging only $4 for both the insured and uninsured. They are rolling the program out in Tampa, Florida with the intention of phasing it into all Wal-Mart stores in Florida.

Now the department store chain Target, has announced it will match Wal-Mart’s $4 rate in the Tampa area.

Wal-Mart plans to add more drugs to the $4 price list, about 300 generic drugs in all. If the program proves successful, they will extend the plan to other parts of the US.

Target Matches Wal-Mart’s $4 Generic RX Price.

Also see related article in Fifty-Something Women.

The Food and Drug Administration has approved several generic versions of the Boehring Ingelheim’s Mobic Tablets, (Meloxicam) a popular NSAID (non-steroidal anti-inflammatory) used in the treatment of osteoarthritis and rheumatoid arthritis.

Meloxicam is an extremely popular drug, ranking 38th in dollar sales of brand-name drugs in the United States. A generic alternative will mean significant savings for patients. The approval of generic drugs can effectively aid in the lowering of health care costs and currently are used to fill more than 50% of all prescriptions written in the U.S.